APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Oocyte Cryopreservation Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oocyte Cryopreservation Service Market Outlook and Growth Opportunities 2026

Report ID 17420619046 January 2026198 pages

Choose your research edition.

Industry ResearchOocyte Cryopreservation Service Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Oocyte Cryopreservation Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Oocyte Cryopreservation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oocyte Cryopreservation Service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Oocyte Cryopreservation Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Oocyte Cryopreservation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oocyte Cryopreservation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oocyte Cryopreservation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oocyte Cryopreservation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oocyte Cryopreservation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oocyte Cryopreservation Service market include Prelude Fertility, CReATe Fertility Center, Anova Fertility, San Diego Fertility Center (SDFC), Extend Fertility, Shady Grove Fertility, Mayo Clinic, Reproductive Biology Associates and CCRM IVF, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Oocyte Cryopreservation Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oocyte Cryopreservation Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oocyte Cryopreservation Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Oocyte Cryopreservation Service market.

Oocyte Cryopreservation Service Segment by Company

Prelude Fertility

CReATe Fertility Center

Anova Fertility

San Diego Fertility Center (SDFC)

Extend Fertility

Shady Grove Fertility

Mayo Clinic

Reproductive Biology Associates

CCRM IVF

HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)

Kindbody

West Coast Fertility Centers

Ruizhimei

Oocyte Cryopreservation Service Segment by Type

Slow-cooling Method

Flash-freezing Process (Vitrification)

Oocyte Cryopreservation Service Segment by Application

25-30 Year Old Female

30-35 Year Old Female

35-40 Year Old Female

Others

Oocyte Cryopreservation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oocyte Cryopreservation Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Oocyte Cryopreservation Service key companies, revenue, market share, and recent developments.

3. To split the Oocyte Cryopreservation Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Oocyte Cryopreservation Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oocyte Cryopreservation Service significant trends, drivers, influence factors in global and regions.

6. To analyze Oocyte Cryopreservation Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oocyte Cryopreservation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oocyte Cryopreservation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oocyte Cryopreservation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oocyte Cryopreservation Service industry.

Chapter 3: Detailed analysis of Oocyte Cryopreservation Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Oocyte Cryopreservation Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Oocyte Cryopreservation Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oocyte Cryopreservation Service Industry Trends Table 2. Oocyte Cryopreservation Service Industry Drivers Table 3. Oocyte Cryopreservation Service Industry Opportunities and Challenges Table 4. Oocyte Cryopreservation Service Industry Restraints Table 5. Global Oocyte Cryopreservation Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oocyte Cryopreservation Service Revenue Share by Company (2021-2026) Table 7. Global Oocyte Cryopreservation Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Oocyte Cryopreservation Service Key Company Manufacturing Base & Headquarters Table 9. Global Oocyte Cryopreservation Service Company, Product Type & Application Table 10. Global Oocyte Cryopreservation Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Oocyte Cryopreservation Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Slow-cooling Method Table 15. Significant Companies of Flash-freezing Process (Vitrification) Table 16. Global Oocyte Cryopreservation Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Oocyte Cryopreservation Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Oocyte Cryopreservation Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Oocyte Cryopreservation Service Sales Value Share by Type (2021-2026) Table 20. Global Oocyte Cryopreservation Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of 25-30 Year Old Female Table 22. Significant Companies of 30-35 Year Old Female Table 23. Significant Companies of 35-40 Year Old Female Table 24. Significant Companies of Others Table 25. Global Oocyte Cryopreservation Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Oocyte Cryopreservation Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Oocyte Cryopreservation Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Oocyte Cryopreservation Service Sales Value Share by Application (2021-2026) Table 29. Global Oocyte Cryopreservation Service Sales Value Share by Application (2027-2032) Table 30. Global Oocyte Cryopreservation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Oocyte Cryopreservation Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Oocyte Cryopreservation Service Sales Value Share by Region (2021-2026) Table 33. Global Oocyte Cryopreservation Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Oocyte Cryopreservation Service Sales Value Share by Region (2027-2032) Table 35. Global Oocyte Cryopreservation Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Oocyte Cryopreservation Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Oocyte Cryopreservation Service Sales Value Market Share by Country (2021-2026) Table 38. Global Oocyte Cryopreservation Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Oocyte Cryopreservation Service Sales Value Market Share by Country (2027-2032) Table 40. Prelude Fertility Company Information Table 41. Prelude Fertility Business Overview Table 42. Prelude Fertility Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Prelude Fertility Oocyte Cryopreservation Service Product Portfolio Table 44. Prelude Fertility Recent Development Table 45. CReATe Fertility Center Company Information Table 46. CReATe Fertility Center Business Overview Table 47. CReATe Fertility Center Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. CReATe Fertility Center Oocyte Cryopreservation Service Product Portfolio Table 49. CReATe Fertility Center Recent Development Table 50. Anova Fertility Company Information Table 51. Anova Fertility Business Overview Table 52. Anova Fertility Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Anova Fertility Oocyte Cryopreservation Service Product Portfolio Table 54. Anova Fertility Recent Development Table 55. San Diego Fertility Center (SDFC) Company Information Table 56. San Diego Fertility Center (SDFC) Business Overview Table 57. San Diego Fertility Center (SDFC) Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. San Diego Fertility Center (SDFC) Oocyte Cryopreservation Service Product Portfolio Table 59. San Diego Fertility Center (SDFC) Recent Development Table 60. Extend Fertility Company Information Table 61. Extend Fertility Business Overview Table 62. Extend Fertility Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Extend Fertility Oocyte Cryopreservation Service Product Portfolio Table 64. Extend Fertility Recent Development Table 65. Shady Grove Fertility Company Information Table 66. Shady Grove Fertility Business Overview Table 67. Shady Grove Fertility Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Shady Grove Fertility Oocyte Cryopreservation Service Product Portfolio Table 69. Shady Grove Fertility Recent Development Table 70. Mayo Clinic Company Information Table 71. Mayo Clinic Business Overview Table 72. Mayo Clinic Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Mayo Clinic Oocyte Cryopreservation Service Product Portfolio Table 74. Mayo Clinic Recent Development Table 75. Reproductive Biology Associates Company Information Table 76. Reproductive Biology Associates Business Overview Table 77. Reproductive Biology Associates Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Reproductive Biology Associates Oocyte Cryopreservation Service Product Portfolio Table 79. Reproductive Biology Associates Recent Development Table 80. CCRM IVF Company Information Table 81. CCRM IVF Business Overview Table 82. CCRM IVF Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. CCRM IVF Oocyte Cryopreservation Service Product Portfolio Table 84. CCRM IVF Recent Development Table 85. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Company Information Table 86. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Business Overview Table 87. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Service Product Portfolio Table 89. HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Development Table 90. Kindbody Company Information Table 91. Kindbody Business Overview Table 92. Kindbody Oocyte Cryopreservation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Kindbody Oocyte Cryopreservation Service Product Portfolio Table 94. Kindbody Recent Development Table 95. West Coast Fertility Centers Company Information Table 96. West Coast Fertility Centers Business Overview Table 97. West Coast Fertility Centers Oocyte Cryopreservation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. West Coast Fertility Centers Oocyte Cryopreservation Service Product Portfolio Table 99. West Coast Fertility Centers Recent Development Table 100. Ruizhimei Company Information Table 101. Ruizhimei Business Overview Table 102. Ruizhimei Oocyte Cryopreservation Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Ruizhimei Oocyte Cryopreservation Service Product Portfolio Table 104. Ruizhimei Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Oocyte Cryopreservation Service Product Image Figure 2. Global Oocyte Cryopreservation Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oocyte Cryopreservation Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Oocyte Cryopreservation Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Slow-cooling Method Image Figure 8. Flash-freezing Process (Vitrification) Image Figure 9. Global Oocyte Cryopreservation Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Oocyte Cryopreservation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Oocyte Cryopreservation Service Sales Value Share by Type (2021-2032) Figure 12. 25-30 Year Old Female Image Figure 13. 30-35 Year Old Female Image Figure 14. 35-40 Year Old Female Image Figure 15. Others Image Figure 16. Global Oocyte Cryopreservation Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Oocyte Cryopreservation Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Oocyte Cryopreservation Service Sales Value Share by Application (2021-2032) Figure 19. Global Oocyte Cryopreservation Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Oocyte Cryopreservation Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Oocyte Cryopreservation Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Oocyte Cryopreservation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Oocyte Cryopreservation Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Oocyte Cryopreservation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Oocyte Cryopreservation Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Oocyte Cryopreservation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Oocyte Cryopreservation Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Oocyte Cryopreservation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Oocyte Cryopreservation Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Oocyte Cryopreservation Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Slow-cooling Method
  • Flash-freezing Process (Vitrification)
Applications
  • 25-30 Year Old Female
  • 30-35 Year Old Female
  • 35-40 Year Old Female
  • Others
Companies covered
  • Prelude Fertility
  • CReATe Fertility Center
  • Anova Fertility
  • San Diego Fertility Center (SDFC)
  • Extend Fertility
  • Shady Grove Fertility
  • Mayo Clinic
  • Reproductive Biology Associates
  • CCRM IVF
  • HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
  • Kindbody
  • West Coast Fertility Centers
  • Ruizhimei

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oocyte Cryopreservation Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oocyte Cryopreservation Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Oocyte Cryopreservation Service Market Dynamics
  1. 2.1 Oocyte Cryopreservation Service Industry Trends
  2. 2.2 Oocyte Cryopreservation Service Industry Drivers
  3. 2.3 Oocyte Cryopreservation Service Industry Opportunities and Challenges
  4. 2.4 Oocyte Cryopreservation Service Industry Restraints
3 Oocyte Cryopreservation Service Market by Company
  1. 3.1 Global Oocyte Cryopreservation Service Company Revenue Ranking in 2025
  2. 3.2 Global Oocyte Cryopreservation Service Revenue by Company (2021-2026)
  3. 3.3 Global Oocyte Cryopreservation Service Company Ranking (2024-2026)
  4. 3.4 Global Oocyte Cryopreservation Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Oocyte Cryopreservation Service Company Product Type and Application
  6. 3.6 Global Oocyte Cryopreservation Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Oocyte Cryopreservation Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Oocyte Cryopreservation Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Oocyte Cryopreservation Service Market by Type
  1. 4.1 Oocyte Cryopreservation Service Type Introduction
  2. 4.1.1 Slow-cooling Method
  3. 4.1.2 Flash-freezing Process (Vitrification)
  4. 4.2 Global Oocyte Cryopreservation Service Sales Value by Type
  5. 4.2.1 Global Oocyte Cryopreservation Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oocyte Cryopreservation Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Oocyte Cryopreservation Service Sales Value Share by Type (2021-2032)
5 Oocyte Cryopreservation Service Market by Application
  1. 5.1 Oocyte Cryopreservation Service Application Introduction
  2. 5.1.1 25-30 Year Old Female
  3. 5.1.2 30-35 Year Old Female
  4. 5.1.3 35-40 Year Old Female
  5. 5.1.4 Others
  6. 5.2 Global Oocyte Cryopreservation Service Sales Value by Application
  7. 5.2.1 Global Oocyte Cryopreservation Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Oocyte Cryopreservation Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Oocyte Cryopreservation Service Sales Value Share by Application (2021-2032)
6 Oocyte Cryopreservation Service Regional Value Analysis
  1. 6.1 Global Oocyte Cryopreservation Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oocyte Cryopreservation Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Oocyte Cryopreservation Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Oocyte Cryopreservation Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oocyte Cryopreservation Service Sales Value (2021-2032)
  7. 6.3.2 North America Oocyte Cryopreservation Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Oocyte Cryopreservation Service Sales Value (2021-2032)
  10. 6.4.2 Europe Oocyte Cryopreservation Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Oocyte Cryopreservation Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Oocyte Cryopreservation Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Oocyte Cryopreservation Service Sales Value (2021-2032)
  16. 6.6.2 South America Oocyte Cryopreservation Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Oocyte Cryopreservation Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Oocyte Cryopreservation Service Sales Value Share by Country, 2025 VS 2032
7 Oocyte Cryopreservation Service Country-level Value Analysis
  1. 7.1 Global Oocyte Cryopreservation Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oocyte Cryopreservation Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Oocyte Cryopreservation Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Oocyte Cryopreservation Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Oocyte Cryopreservation Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Oocyte Cryopreservation Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Oocyte Cryopreservation Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Prelude Fertility
  2. 8.1.1 Prelude Fertility Company Information
  3. 8.1.2 Prelude Fertility Business Overview
  4. 8.1.3 Prelude Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Prelude Fertility Oocyte Cryopreservation Service Product Portfolio
  6. 8.1.5 Prelude Fertility Recent Developments
  7. 8.2 CReATe Fertility Center
  8. 8.2.1 CReATe Fertility Center Company Information
  9. 8.2.2 CReATe Fertility Center Business Overview
  10. 8.2.3 CReATe Fertility Center Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CReATe Fertility Center Oocyte Cryopreservation Service Product Portfolio
  12. 8.2.5 CReATe Fertility Center Recent Developments
  13. 8.3 Anova Fertility
  14. 8.3.1 Anova Fertility Company Information
  15. 8.3.2 Anova Fertility Business Overview
  16. 8.3.3 Anova Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Anova Fertility Oocyte Cryopreservation Service Product Portfolio
  18. 8.3.5 Anova Fertility Recent Developments
  19. 8.4 San Diego Fertility Center (SDFC)
  20. 8.4.1 San Diego Fertility Center (SDFC) Company Information
  21. 8.4.2 San Diego Fertility Center (SDFC) Business Overview
  22. 8.4.3 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 San Diego Fertility Center (SDFC) Oocyte Cryopreservation Service Product Portfolio
  24. 8.4.5 San Diego Fertility Center (SDFC) Recent Developments
  25. 8.5 Extend Fertility
  26. 8.5.1 Extend Fertility Company Information
  27. 8.5.2 Extend Fertility Business Overview
  28. 8.5.3 Extend Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Extend Fertility Oocyte Cryopreservation Service Product Portfolio
  30. 8.5.5 Extend Fertility Recent Developments
  31. 8.6 Shady Grove Fertility
  32. 8.6.1 Shady Grove Fertility Company Information
  33. 8.6.2 Shady Grove Fertility Business Overview
  34. 8.6.3 Shady Grove Fertility Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shady Grove Fertility Oocyte Cryopreservation Service Product Portfolio
  36. 8.6.5 Shady Grove Fertility Recent Developments
  37. 8.7 Mayo Clinic
  38. 8.7.1 Mayo Clinic Company Information
  39. 8.7.2 Mayo Clinic Business Overview
  40. 8.7.3 Mayo Clinic Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mayo Clinic Oocyte Cryopreservation Service Product Portfolio
  42. 8.7.5 Mayo Clinic Recent Developments
  43. 8.8 Reproductive Biology Associates
  44. 8.8.1 Reproductive Biology Associates Company Information
  45. 8.8.2 Reproductive Biology Associates Business Overview
  46. 8.8.3 Reproductive Biology Associates Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Reproductive Biology Associates Oocyte Cryopreservation Service Product Portfolio
  48. 8.8.5 Reproductive Biology Associates Recent Developments
  49. 8.9 CCRM IVF
  50. 8.9.1 CCRM IVF Company Information
  51. 8.9.2 CCRM IVF Business Overview
  52. 8.9.3 CCRM IVF Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 CCRM IVF Oocyte Cryopreservation Service Product Portfolio
  54. 8.9.5 CCRM IVF Recent Developments
  55. 8.10 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group)
  56. 8.10.1 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Company Information
  57. 8.10.2 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Business Overview
  58. 8.10.3 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Oocyte Cryopreservation Service Product Portfolio
  60. 8.10.5 HRC Fertility (Jinxin Fertility Group) (Jinxin Fertility Group) Recent Developments
  61. 8.11 Kindbody
  62. 8.11.1 Kindbody Company Information
  63. 8.11.2 Kindbody Business Overview
  64. 8.11.3 Kindbody Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kindbody Oocyte Cryopreservation Service Product Portfolio
  66. 8.11.5 Kindbody Recent Developments
  67. 8.12 West Coast Fertility Centers
  68. 8.12.1 West Coast Fertility Centers Company Information
  69. 8.12.2 West Coast Fertility Centers Business Overview
  70. 8.12.3 West Coast Fertility Centers Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 West Coast Fertility Centers Oocyte Cryopreservation Service Product Portfolio
  72. 8.12.5 West Coast Fertility Centers Recent Developments
  73. 8.13 Ruizhimei
  74. 8.13.1 Ruizhimei Company Information
  75. 8.13.2 Ruizhimei Business Overview
  76. 8.13.3 Ruizhimei Oocyte Cryopreservation Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ruizhimei Oocyte Cryopreservation Service Product Portfolio
  78. 8.13.5 Ruizhimei Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst